11 November 2020 in International Urogynecology Journal
KMKyannie Risame Ueda da Mata
Kyannie Risame Ueda da Mata
RCRafaela Cristina Monica Costa
Rafaela Cristina Monica Costa
ÉCÉbe dos Santos Monteiro Carbone
Ébe dos Santos Monteiro Carbone
MBMaria Augusta Tezelli Bortolini
Maria Augusta Tezelli Bortolini
+1
23 August 2019 in International Urogynecology Journal
LFLetícia de Azevedo Ferreira
Letícia de Azevedo Ferreira
MMMayanni Magda Perreira Matias
Mayanni Magda Perreira Matias
MBMaria Augusta Tezelli Bortolini
Maria Augusta Tezelli Bortolini
17 March 2012 in International Urogynecology Journal
ARAna Paula Magalhães Resende
Ana Paula Magalhães Resende
MGManoel João Batista Castello Girão
Manoel João Batista Castello Girão
7 February 2017 in Neurourology and Urodynamics
MBMaria Augusta Tezelli Bortolini
Maria Augusta Tezelli Bortolini
MGManoel João Batista Castello Girão
Manoel João Batista Castello Girão
31 May 2023 in International Urogynecology Journal
MBMaria Augusta Tezelli Bortolini
Maria Augusta Tezelli Bortolini
GPGláucia Miranda Varella Pereira
Gláucia Miranda Varella Pereira
GSGisela Rosa Franco Salerno
Gisela Rosa Franco Salerno
1 December 2017 in Revista da Associação Médica Brasileira
Summary Introduction: Pelvic floor muscle training (PFMT) involves the contraction of the puborectal, anal sphincter and external urethral muscles, inhibiting the detrusor contraction, what justify its use in the treatment of overactive bladder (OAB) symptoms. Objective: To verify the effects of isolated PFMT on the symptoms of OAB. Method: Prospective clinical trial with 27 women with mixed urinary incontinence (MUI), with predominance of OAB symptoms and loss ≥ 2 g in the pad test. It was evaluated: pelvic floor muscles (PFMs) function (digital palpation and manometry); urinary symptoms (nocturia, frequency and urinary loss); degree of discomfort of OAB symptoms; and quality of life (Incontinence Quality-of-Life Questionnaire [I-QoL]). The PFMT program consisted of 24 outpatient sessions (2x/week + home PFMT). The Mann-Whitney and Wilcoxon tests (with a significance level of 5%) were used to analyse the data. Results: There was a significant improvement of the urinary symptoms to the pad test (5.8±9.7, p<0.001), urinary loss (0.7±1.1, p=0.005) and nocturia (0.8±0.9, p=0.011). Reduction in the degree of discomfort of urinary symptoms was observed according to OAB-V8 questionnaire (10.0±7.7, p=0.001). There were also significant results in PFMs function: Oxford (3.6±0.9, p=0.001), endurance (5.2±1.8, p<0.001), fast (8.9±1.5, p<0.001) and manometry (26.6±15.8, p=0.003). In addition, quality of life had a significant improvement in the three domains evaluated by I-QoL. Conclusion: The PFMT without any additional guidelines improves the symptomatology, the function of PFMs and the quality of life of women with OAB symptoms.